These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 31841131)
21. A retrospective study on evaluation of anti-hypertensive drugs used in gestational hypertension. Prabahar K; Katikam T; Punniyakotti S; Devanandan P Pak J Pharm Sci; 2019 Jan; 32(1):213-215. PubMed ID: 30772811 [TBL] [Abstract][Full Text] [Related]
22. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population. Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131 [TBL] [Abstract][Full Text] [Related]
23. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy. Shawkat E; Mistry H; Chmiel C; Webster L; Chappell L; Johnstone ED; Myers JE Pregnancy Hypertens; 2018 Jan; 11():92-98. PubMed ID: 29523282 [TBL] [Abstract][Full Text] [Related]
24. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure? Magee LA; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort W; Welch R; Thornton JG; Moutquin JM; Hypertension; 2016 Nov; 68(5):1153-1159. PubMed ID: 27620393 [TBL] [Abstract][Full Text] [Related]
25. Hypertensive Disorders of Pregnancy. Khedagi AM; Bello NA Cardiol Clin; 2021 Feb; 39(1):77-90. PubMed ID: 33222817 [TBL] [Abstract][Full Text] [Related]
26. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial. Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW; BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705 [TBL] [Abstract][Full Text] [Related]
27. Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies. Wang Y; Shi D; Chen L J Clin Hypertens (Greenwich); 2018 Feb; 20(2):394-399. PubMed ID: 29316154 [TBL] [Abstract][Full Text] [Related]
29. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM BJOG; 2016 Jun; 123(7):1143-51. PubMed ID: 26265372 [TBL] [Abstract][Full Text] [Related]
30. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. Clark SM; Dunn HE; Hankins GD Semin Perinatol; 2015 Nov; 39(7):548-55. PubMed ID: 26344738 [TBL] [Abstract][Full Text] [Related]
32. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006 [TBL] [Abstract][Full Text] [Related]
34. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781 [TBL] [Abstract][Full Text] [Related]
35. New Evidence in the Management of Chronic Hypertension in Pregnancy. Podymow T; August P Semin Nephrol; 2017 Jul; 37(4):398-403. PubMed ID: 28711079 [TBL] [Abstract][Full Text] [Related]
36. Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension. Greene NH; Pon FF; Kilpatrick SJ J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10103-10109. PubMed ID: 36042568 [TBL] [Abstract][Full Text] [Related]
37. Factors associated with appropriate treatment of acute-onset severe obstetrical hypertension. Deshmukh US; Lundsberg LS; Culhane JF; Partridge C; Reddy UM; Merriam AA; Son M Am J Obstet Gynecol; 2021 Sep; 225(3):329.e1-329.e10. PubMed ID: 34023314 [TBL] [Abstract][Full Text] [Related]
38. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Shekhar S; Sharma C; Thakur S; Verma S Obstet Gynecol; 2013 Nov; 122(5):1057-1063. PubMed ID: 24104790 [TBL] [Abstract][Full Text] [Related]
39. Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo. Xiang X; Wang F; Zhao N; Zhou Z Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):9-13. PubMed ID: 34174970 [TBL] [Abstract][Full Text] [Related]
40. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. Raheem IA; Saaid R; Omar SZ; Tan PC BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]